MAP PHARMACEUTICALS, INC. Net Change in Cash
MAP PHARMACEUTICALS, INC. reported Net Change in Cash of $114.22 million for the 111-month period ending 2012-09-30, per its 10-Q filed 2012-11-06.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2012-11-06
- MAP PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2012-09-30 was $45.80M, a 446.33% increase year-over-year.
- MAP PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2012-06-30 was -$10.58M.
- MAP PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2012-03-31 was -$19.81M, a 151.01% decline year-over-year.
- MAP PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2011-12-31 was -$13.03M, a 138.10% decline year-over-year.
- MAP PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2011 was $22.81M, a 122.94% increase from fiscal 2010.
- MAP PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2010 was $10.23M, a 69.77% decline from fiscal 2009.
- MAP PHARMACEUTICALS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2009 was $33.85M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 96 month | Cash and Cash Equivalents, Period Increase (Decrease) 99 month | Cash and Cash Equivalents, Period Increase (Decrease) 102 month | Cash and Cash Equivalents, Period Increase (Decrease) 105 month | Cash and Cash Equivalents, Period Increase (Decrease) 108 month | Cash and Cash Equivalents, Period Increase (Decrease) 111 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2012-09-30 | $45.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $35.22M derived: sum of 2 quarters · filed 2012-11-06 | $15.40M 10-Q · filed 2012-11-06 | $2.37M derived: sum of 4 quarters · filed 2012-11-06 | $114.22M 10-Q · filed 2012-11-06 | |||||
| 2012-06-30 | -$10.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | -$30.40M 10-Q · filed 2012-07-27 | -$43.42M derived: sum of 3 quarters · filed 2012-07-27 | -$35.04M derived: sum of 4 quarters · filed 2012-11-06 | $68.42M 10-Q · filed 2012-07-27 | |||||
| 2012-03-31 | -$19.81M 10-Q · filed 2012-05-08 | -$32.84M derived: sum of 2 quarters · filed 2012-05-08 | -$24.46M derived: sum of 3 quarters · filed 2012-11-06 | -$35.84M derived: sum of 4 quarters · filed 2012-11-06 | $79.00M 10-Q · filed 2012-05-08 | |||||
| 2011-12-31 | -$13.03M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$4.64M derived: sum of 2 quarters · filed 2012-11-06 | -$16.03M derived: sum of 3 quarters · filed 2012-11-06 | $22.81M 10-K · filed 2012-03-30 | $98.82M 10-K · filed 2012-03-30 | |||||
| 2011-09-30 | $8.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | -$3.00M derived: sum of 2 quarters · filed 2012-11-06 | $35.84M 10-Q · filed 2012-11-06 | $70.03M derived: sum of 4 quarters · filed 2012-11-06 | $111.84M 10-Q/A · filed 2012-03-30 | |||||
| 2011-06-30 | -$11.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27 | $27.45M 10-Q · filed 2012-07-27 | $61.65M derived: sum of 3 quarters · filed 2012-07-27 | $48.13M derived: sum of 4 quarters · filed 2012-07-27 | $103.46M 10-Q/A · filed 2012-03-30 | |||||
| 2011-03-31 | $38.84M 10-Q · filed 2012-05-08 | $73.03M derived: sum of 2 quarters · filed 2012-05-08 | $59.52M derived: sum of 3 quarters · filed 2012-05-08 | |||||||
| 2010-12-31 | $34.19M derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-30 | $20.68M derived: sum of 2 quarters · filed 2012-03-30 | $10.23M 10-K · filed 2012-03-30 | |||||||
| 2010-09-30 | -$13.51M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-30 | -$23.96M 10-Q/A · filed 2012-03-30 | ||||||||
| 2010-06-30 | -$10.45M 10-Q/A · filed 2012-03-30 | |||||||||
| 2009-12-31 | $33.85M 10-K · filed 2012-03-30 |